Product · #6 of 27 · menopause + weight

Estroven Menopause Relief + Weight Management

Capsule from Estroven, made by i-Health (dsm-firmenich). Daily serving: 1 capsule.

Last updated · Price and ratings checked Nov 19, 2026

In short: Estroven Menopause Relief + Weight Management scores 58.4/100 in our ranking (#6 of 27). It costs $0.63 a day at the regular price. Evidence: soy isoflavones 56 mg + black cohosh 40 mg; no product trial; best ingredient grade B- (Soy isoflavones & genistein). No NSF registry listing was confirmed.

Pros

  • Low cost: $0.63 a day at the label dose.
  • Widely reviewed: ★ 4.3 from 16,709 Amazon ratings.
  • Evidence: soy isoflavones 56 mg + black cohosh 40 mg; no product trial.

Cons

  • No NSF registry listing confirmed.
  • Contains black cohosh: rare liver-injury reports, and adulteration is common across the category.
  • Legal or regulatory history: see flags below.

Flags

Class actionWatchdog complaintLiver caution

Score breakdown

Evidence
26/40
NSF-verified testing
4/20
Value ($/day)
15.9/20
Ingredients
6/10
Amazon rating
6.5/10

How we score

Full label: what's in it

Supplement Facts actives per daily serving (1 capsule). Source: label or official page, checked Nov 19, 2026.
Ingredient (as labeled)Per dayEvidence page
Black cohosh root extract (standardization not stated)40 mgBlack cohosh C
Soy isoflavones56 mgSoy isoflavones & genistein B-
CQR-300 Cissus quadrangularis stem & leaf extract300 mgNot in our evidence library

Label read from an older (2022) Supplement Facts image still shown on the product page; the current label was not confirmed. Unverified

Evidence

Our evidence score: 26/40, because: soy isoflavones 56 mg + black cohosh 40 mg; no product trial.

Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.

Ingredient evidence

  • Black cohosh C (40 mg here)
    Black cohosh is the most-studied herb for occasional hot flashes and night sweats associated with menopause*. Independent trials and a Cochrane review found no clear benefit over placebo, other reviews found a small one, and rare liver-injury reports exist. The Menopause Society 2023: Not recommended (Level I) – 'insufficient evidence to support use for VMS'.
  • Soy isoflavones & genistein B- (56 mg here)
    Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials. The Menopause Society 2023: Not recommended (Level II) – mixed evidence.

Studies

Studies on its ingredients (19)
  • Black cohosh (Cimicifuga spp.) for menopausal symptoms.

    Leach MJ, Moore V · Cochrane Database Syst Rev 2012 · Black cohosh

    An independent Cochrane review pooled 16 trials with about 2,000 women taking black cohosh (usually 40 mg a day for around 5 months). Women taking black cohosh did not have fewer hot flashes than women on a dummy pill, and the reviewers called the safety data inconclusive.

    Who
    16 RCTs, 2,027 women
    Dose
    median 40 mg/day black cohosh extract
    Duration
    mean 23 weeks
    Result
    No difference vs placebo in hot-flush frequency (MD +0.07/day; 95% CI -0.43 to 0.56; 3 trials, 393 women) or symptom scores; hormone therapy beat black cohosh.
    Funding
    Cochrane review (independent). Independent / academic

    PubMed · Full text (DOI)

  • Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis.

    Sadahiro R, Matsuoka LN, Zeng BS et al. · Menopause 2023 · Black cohosh

    A 2023 analysis of 22 studies (about 2,300 women) found black cohosh extracts did somewhat better than placebo for overall menopause symptoms and hot flashes, with a small-to-moderate effect. It did not help anxiety or low mood, and the studies varied a lot in product and quality.

    Who
    22 articles, 2,310 women
    Dose
    various black cohosh extracts
    Duration
    various
    Result
    Pooled improvement vs placebo in overall menopausal symptoms (Hedges g 0.58) and hot flashes (g 0.32); no significant effect on anxiety or depression.
    Funding
    Academic; one author reported speaker fees from supplement/pharma companies incl. Cimic. Some author ties

    PubMed · Full text (DOI)

  • Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence.

    Castelo-Branco C, Gambacciani M, Cano A et al. · Climacteric 2021 · Black cohosh, St John's wort + black cohosh

    This review looked only at the specific black cohosh extract in Remifemin and found it beat placebo for menopause symptoms, especially at higher doses or combined with St John's wort. Several authors work for the company that makes Remifemin, so read it as a manufacturer-backed summary.

    Who
    35 studies + 1 MA, 43,759 women (13,096 on iCR)
    Dose
    isopropanolic extract (iCR, Remifemin), 20–>40 mg/day
    Duration
    various
    Result
    SMD -0.69 vs placebo for neurovegetative/psychological symptoms; larger effect at higher dose and with St John's wort; no hepatotoxicity signal in trial data.
    Funding
    Co-authored by staff of Schaper & Brümmer (maker of Remifemin) – manufacturer-affiliated. Industry-linked

    PubMed · Full text (DOI)

  • Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.

    Osmers R, Friede M, Liske E et al. · Obstet Gynecol 2005 · Black cohosh

    About 300 women with menopause symptoms took Remifemin-type black cohosh (40 mg a day) or a dummy pill for 12 weeks. Symptom scores improved more with black cohosh, mostly in women early in menopause, and side effects were similar to placebo.

    Who
    304 women
    Dose
    iCR (Remifemin) equivalent to 40 mg root/day
    Duration
    12 weeks
    Result
    More effective than placebo on the Menopause Rating Scale (P<.001), mainly in early menopause; hot-flush subscore was the most responsive.
    Funding
    Funding not stated in the abstract (study of the manufacturer's extract). Funding not stated

    PubMed · Full text (DOI)

  • Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.

    Pockaj BA, Gallagher JG, Loprinzi CL et al. · J Clin Oncol 2006 · Black cohosh

    In a publicly funded US trial, 132 women took black cohosh (20 mg twice a day) or placebo for 4 weeks each. Hot flashes dropped slightly more on placebo than on black cohosh, so the trial found no benefit.

    Who
    132 women (history of or concern about breast cancer; crossover)
    Dose
    black cohosh 20 mg twice daily
    Duration
    two 4-week periods (crossover)
    Result
    Hot-flash frequency fell 17% on black cohosh vs 26% on placebo (P=.36) – no benefit.
    Funding
    NCCTG/NCI cooperative group (public funding). Independent / academic

    PubMed · Full text (DOI)

  • Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.

    Newton KM, Reed SD, LaCroix AZ et al. · Ann Intern Med 2006 · Black cohosh, Soy isoflavones & genistein

    The US government-funded HALT study followed 351 women for a year. Black cohosh (160 mg a day), a 10-herb blend, and the blend plus more soy food did no better than a dummy pill for hot flashes, while hormone therapy clearly worked.

    Who
    351 women aged 45–55
    Dose
    black cohosh 160 mg/day; multibotanical; multibotanical + soy diet; hormone therapy; placebo
    Duration
    12 months
    Result
    No herbal arm differed from placebo at 3, 6 or 12 months (<1 hot flash/day difference); hormone therapy reduced ~4 symptoms/day vs placebo.
    Funding
    US NIH (NCCAM/NIA) – HALT study, independent. Independent / academic

    PubMed · Full text (DOI)

  • Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.

    Geller SE, Shulman LP, van Breemen RB et al. · Menopause 2009 · Black cohosh, Red clover

    In a year-long, government-funded trial, women took black cohosh, red clover, hormone therapy or a dummy pill. Only hormones beat placebo for hot flashes; both herbs looked safe but did not reduce hot flashes more than placebo.

    Who
    89 women (4 arms)
    Dose
    standardized black cohosh and red clover extracts vs CEE/MPA vs placebo
    Duration
    12 months
    Result
    Hot-flash reduction: black cohosh 34%, red clover 57%, placebo 63%, hormones 94%; neither botanical beat placebo. Both appeared safe over 12 months.
    Funding
    NIH (NCCAM/ODS) botanical center, University of Illinois – independent. Independent / academic

    PubMed · Full text (DOI)

  • Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.

    Frei-Kleiner S, Schaffner W, Rahlfs VW et al. · Maturitas 2005 · Black cohosh

    122 women took a different (ethanol-based) black cohosh extract or placebo for 12 weeks. Overall it did not beat placebo; only women with more severe symptoms seemed to benefit, which is a weaker, after-the-fact finding.

    Who
    122 women with ≥3 hot flashes/day
    Dose
    dried ethanolic black cohosh extract (non-Remifemin)
    Duration
    12 weeks
    Result
    No superiority over placebo overall; benefit only in subgroup with moderate–severe symptoms (Kupperman ≥20: -47% vs -21%).
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract.

    Naser B, Schnitker J, Minkin MJ et al. · Menopause 2011 · Black cohosh

    This analysis of 5 trials found no change in liver blood tests in women taking the Remifemin extract for up to 6 months. It was written by the manufacturer and covers only short-term use.

    Who
    5 RCTs, 1,117 women
    Dose
    iCR 40–128 mg/day
    Duration
    3–6 months
    Result
    No effect on liver enzymes (AST/ALT) vs reference groups.
    Funding
    Written by Schaper & Brümmer (Remifemin maker) staff. Industry-linked

    PubMed · Full text (DOI)

  • United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.

    Mahady GB, Low Dog T, Barrett ML et al. · Menopause 2008 · Black cohosh

    The US Pharmacopeia reviewed 30 reports of liver injury in people using black cohosh. It could not prove black cohosh caused them but recommended a label warning to stop and see a doctor if liver symptoms appear.

    Who
    30 case reports of liver damage
    Dose
    various products
    Duration
    n/a
    Result
    All 30 liver cases rated 'possible' (none probable/certain); USP recommended a cautionary liver label.
    Funding
    US Pharmacopeia expert committee (independent standard-setter). Independent / academic

    PubMed · Full text (DOI)

  • Black cohosh and breast cancer: a systematic review.

    Fritz H, Seely D, McGowan J et al. · Integr Cancer Ther 2014 · Black cohosh

    A systematic review of black cohosh and breast cancer found no sign it increases breast-cancer risk, but also no proof it reduces hot flashes in women who have had breast cancer.

    Who
    26 studies (14 RCTs)
    Dose
    various
    Duration
    various
    Result
    No evidence black cohosh raises breast-cancer risk; no proven hot-flash benefit in breast-cancer patients vs placebo.
    Funding
    Academic (Canadian naturopathic/academic group). Independent / academic

    PubMed · Full text (DOI)

  • Actaea racemosa L. Is More Effective in Combination with Rhodiola rosea L. for Relief of Menopausal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study.

    Pkhaladze L, Davidova N, Khomasuridze A et al. · Pharmaceuticals (Basel) 2020 · Black cohosh, Rhodiola

    220 women in Georgia took black cohosh alone, black cohosh plus Rhodiola, or placebo for 12 weeks; the combination worked best. An author is paid by the company that sells the combination.

    Who
    220 women
    Dose
    black cohosh 6.5 mg; black cohosh 500 mg; Rhodiola+black cohosh (Menopause Relief EP); placebo
    Duration
    12 weeks
    Result
    Rhodiola+black cohosh beat black cohosh alone and placebo on all symptom scales.
    Funding
    Author has contract with Europharma USA (seller) and heads Phytomed AB. Industry-linked

    PubMed · Full text (DOI)

  • Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women's midlife health.

    Maunder A, Mardon AK, Rao V et al. · Climacteric 2026 · Black cohosh, Vitamin D & calcium

    A 2026 International Menopause Society evidence review rated black cohosh's benefit for hot flashes as moderate-certainty and most other supplements as low-certainty.

    Who
    158 studies
    Dose
    various
    Duration
    n/a
    Result
    Moderate-certainty evidence supports black cohosh for vasomotor/menopausal symptoms and vitamin D for fracture risk; most complementary therapies low/very-low certainty.
    Funding
    International Menopause Society review. Independent / academic

    PubMed · Full text (DOI)

  • Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.

    Bai W, Henneicke-von Zepelin HH, Wang S et al. · Maturitas 2007 · Black cohosh

    244 Chinese women took Remifemin-type black cohosh or the hormone-like drug tibolone for 12 weeks. Symptom scores fell similarly in both groups, but there was no placebo group, so the size of the true effect is unclear.

    Who
    244 Chinese women
    Dose
    iCR (Remifemin) equivalent to 40 mg/day vs tibolone 2.5 mg/day (no placebo)
    Duration
    12 weeks
    Result
    Kupperman Index fell similarly with iCR and tibolone; iCR better tolerated.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Phytoestrogens for menopausal vasomotor symptoms.

    Lethaby A, Marjoribanks J, Kronenberg F et al. · Cochrane Database Syst Rev 2013 · Red clover, Soy isoflavones & genistein

    An independent Cochrane review of 43 trials found no conclusive proof that phytoestrogens (soy, red clover) reduce hot flashes. High-genistein soy extracts looked more promising, and placebo effects were large.

    Who
    43 RCTs, 4,364 women
    Dose
    various phytoestrogens
    Duration
    various
    Result
    No conclusive evidence of reduced hot flushes; Promensil (red clover) not better than placebo (MD -0.93/day, NS); genistein >30 mg/day may help; strong placebo effect.
    Funding
    Cochrane review (independent). Independent / academic

    PubMed · Full text (DOI)

  • Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.

    Taku K, Melby MK, Kronenberg F et al. · Menopause 2012 · Soy isoflavones & genistein

    Pooling 17 trials, soy isoflavone supplements (about 54 mg a day) cut hot-flash frequency by about a fifth more than placebo. Products higher in genistein worked better. Results varied widely between studies.

    Who
    17 RCTs in meta-analysis
    Dose
    median 54 mg isoflavones/day
    Duration
    6 weeks–12 months
    Result
    Hot-flash frequency -20.6% and severity -26.2% vs placebo; >18.8 mg genistein about twice as effective.
    Funding
    Academic (Japan/US); funding not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.

    Franco OH, Chowdhury R, Troup J et al. · JAMA 2016 · Red clover, Soy isoflavones & genistein

    A JAMA analysis of 62 studies found plant estrogens such as soy cut about one hot flash a day compared with placebo – a modest effect – and most studies were of low quality.

    Who
    62 studies, 6,653 women
    Dose
    phytoestrogens and other plant therapies
    Duration
    various
    Result
    Phytoestrogens: -1.31 hot flashes/day; soy isoflavones -0.79/day; 74% of RCTs at high risk of bias.
    Funding
    Academic (Erasmus MC); industry co-funding reported in paper is not verified here. Industry-linked

    PubMed · Full text (DOI)

  • Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.

    Unfer V, Casini ML, Costabile L et al. · Fertil Steril 2004 · Soy isoflavones & genistein

    Italian women took high-dose soy isoflavones (150 mg a day) or placebo for 5 years. A small number on soy developed thickening of the womb lining (3.4% vs 0%), so long-term high doses deserve caution.

    Who
    376 women with intact uterus
    Dose
    soy isoflavones 150 mg/day
    Duration
    5 years
    Result
    Endometrial hyperplasia in 3.37% on soy vs 0% placebo; no cancers.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.

    Qiu S, Jiang C · Eur J Nutr 2019 · Soy isoflavones & genistein

    Studies following women with breast cancer found eating soy was linked to lower recurrence, not higher. These looked at soy food, not concentrated supplements.

    Who
    12 cohort studies, 37,275 breast-cancer patients
    Dose
    dietary soy/isoflavone intake
    Duration
    observational
    Result
    Pre- and post-diagnosis soy intake associated with lower recurrence; no harm signal.
    Funding
    Academic. Independent / academic

    PubMed · Full text (DOI)

The Menopause Society's 2023 statement is in the study library.

Price

Regular one-time price$18.99 (30 units, 30 days at label dose)
Cost per day$0.63
SubscriptionAmazon S&S $14.35
Price notes30 ct $18.99; 60 ct $34.99. Amazon B01ANSJV80 list $18.79 (BF $15.11)
In stock when checkedYes
CheckedNov 19, 2026

Ratings

Amazon: ★ 4.3 from 16,709 ratings on Amazon (checked Nov 19, 2026)

Star ratings reflect buyer satisfaction, not clinical effect.

Certifications and claims

Verified in a public registry

  • No registry listing found.

Claims made by the brand

  • “hormone-free” Brand claim
  • “drug-free” Brand claim
  • “contains soy” Brand claim

Registry check: NSF/ANSI 173 (searched 'Estroven', 'i-Health'): not found

Who's behind it

BrandEstroven
Owner / companyi-Health, Inc. (Cromwell, CT), part of the dsm-firmenich group (estroven.com footer '© 2026 dsm-firmenich group').
FoundersNot stated on the pages we read.
Where it's madeOlder label: 'Made in the USA with US and imported materials' (Weight Management SFP); not stated for others.
Medical advisors named
  • Shavon Jackson-Michel, ND (chair; i-Health Global Scientific Engagement Leader)
  • Alexandra Dubinskaya, MD, FACOG, NCMP
  • Christina Kramer, MD, FACOG, NCMP
  • Komkwuan Paruchabutr, DNP, FNP, WHNP, CNM
  • Kerry-Anne Perkins, DO, FACOG
Sourceestroven.com

Flags & safety

Legal, regulatory and quality flags

  • Class action Arnold v. I-Health, Inc. (C.D. Cal. 2:26-cv-01282, filed 2026) alleges Estroven Mood Boost and Stress Relief claims are false/misleading (not the Complete SKU). classaction.org
  • TINA.org warning letter to i-Health re menopause marketing (Oct 2024). truthinadvertising.org
  • Contains black cohosh (see black cohosh adulteration/liver caution in general notes).
  • Systematic review (Natural Product Reports 2024): 42.2% of 322 black cohosh samples across 78 publications adulterated/mislabeled, mainly with Asian Actaea species. pubs.rsc.org
  • DNA barcoding (J AOAC 2012): 9 of 36 (25%) US black cohosh supplements matched Asian Actaea. pubmed.ncbi.nlm.nih.gov
  • ConsumerLab 'Menopause Supplements Review' (soy/red clover isoflavones, black cohosh, progesterone cream) last updated 2026-10-29; product results are members-only (not accessed). Public summary: ≥50 mg soy isoflavones or ≥15 mg genistein / 28 mg daidzein for effect; only 1/3–1/2 of women are equol producers. Past rounds found products with 30–59% of listed isoflavones and a black cohosh product with lead. consumerlab.com

Ingredient safety notes

  • Black cohosh: Rare liver injury reports (USP: 30 cases 'possible' causality; ODS: ≥83 cases worldwide, causality unproven). USP-recommended label: discontinue if liver disorder or symptoms of liver trouble. No evidence of increased breast-cancer risk (Fritz 2014), but safety after breast cancer not established (NCCIH). Possible interaction with statins (NCCIH).
  • Soy isoflavones & genistein: Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH).

Not verified

  • Current label (we read an older 2022 label image). Unverified

Sources

Talk to a clinician first

The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).

If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.